Literature DB >> 12358789

Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus.

A Kinoshita1, C M Whelan, C J Smith, O Berezovska, B T Hyman.   

Abstract

Amyloid-beta, the peptide that deposits as senile plaques in Alzheimer's disease, is derived from the amyloid precursor protein (APP) by a gamma secretase-mediated intramembranous cleavage. In addition to amyloid-beta, this cleavage produces a carboxyl-terminal intracellular fragment which has an unknown function. The carboxyl-terminal domain of APP interacts in the cytoplasm with an adapter protein, Fe65. We demonstrate by laser scanning confocal microscopy that a gamma secretase generated APP carboxyl-terminal domain, tagged with green fluorescent protein (GFP), translocates to the nucleus in a manner dependent upon stabilization by the adapter protein Fe65; APP which has been mutated to block interactions with Fe65 cannot be detected in the nucleus. The APP-CT domain continues to interact with Fe65 in the nucleus, as determined by both colocalization and fluorescence resonance energy transfer (FRET). Visualization of the APP-CT-Fe65 complex in the nucleus may serve as a readout for processes that modify gamma secretase release of APP-CT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358789     DOI: 10.1046/j.1471-4159.2002.01016.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

2.  A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein.

Authors:  Matthew R Hass; Bruce A Yankner
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

3.  N-cadherin-based adhesion enhances Abeta release and decreases Abeta42/40 ratio.

Authors:  Kengo Uemura; Christina M Lill; Mary Banks; Megumi Asada; Nobuhisa Aoyagi; Koichi Ando; Masakazu Kubota; Takeshi Kihara; Takaaki Nishimoto; Hachiro Sugimoto; Ryosuke Takahashi; Bradley T Hyman; Shun Shimohama; Oksana Berezovska; Ayae Kinoshita
Journal:  J Neurochem       Date:  2008-11-25       Impact factor: 5.372

4.  Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65.

Authors:  Junying Bao; Chuanhai Cao; Xiaohui Zhang; Feng Jiang; Santo V Nicosia; Wenlong Bai
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

5.  The cleavage products of amyloid-beta precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites.

Authors:  Virgil Muresan; Nicholas H Varvel; Bruce T Lamb; Zoia Muresan
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

6.  Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions.

Authors:  Xuejing Li; Kengo Uemura; Tadafumi Hashimoto; Navine Nasser-Ghodsi; Muriel Arimon; Christina M Lill; Isabella Palazzolo; Dimitri Krainc; Bradley T Hyman; Oksana Berezovska
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

7.  Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD.

Authors:  Brandon Beagle; Gail V W Johnson
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

Review 8.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

Review 9.  Cytoplasmic tail adaptors of Alzheimer's amyloid-beta protein precursor.

Authors:  Masaoki Kawasumi; Shuji Matsuda; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

Review 10.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.